US Stocks
BTAI

BioXcel Therapeutics, Inc. Common Stock

$1.59
+0.04 (+2.25%)

Volume:

316.557K ($512.38K)

Market Capitalization:

$34.77M

BioXcel Therapeutics Price Chart

BioXcel Therapeutics Price Chart 11:59 AM 1:19 PM 2:39 PM 3:59 PM 5:19 PM 6:39 PM 7:59 PM1.641.621.611.601.591.581.56

BioXcel Therapeutics Volume Chart

BioXcel Therapeutics Volume Chart 11:59 AM1:19 PM2:39 PM3:59 PM5:19 PM6:39 PM7:59 PM 17.27K14.80K12.34K9.87K7.40K4.93K2.47K

BioXcel Therapeutics Market Segments

After Hours

-0.01(-0.63%)
Open$1.60
Close$1.59
Low$1.58
Low Change-0.02 (-1.25%)
High$1.62
High Change+0.02 (+1.25%)
Range$0.04
Volume5.933K
Dollar Volume$9.43K

Regular Trading Hours

+0.05(+3.18%)
Open$1.57
Close$1.62
Low$1.53
Low Change-0.04 (-2.55%)
High$1.64
High Change+0.07 (+4.14%)
Range$0.11
Volume303.989K
Dollar Volume$492.46K

Premarket

-0.01(-0.63%)
Open$1.59
Close$1.58
Low$1.56
Low Change-0.03 (-1.89%)
High$1.61
High Change+0.02 (+1.26%)
Range$0.05
Volume6.635K
Dollar Volume$10.48K

After Hours Yesterday

+0.01(+0.64%)
Open$1.56
Close$1.57
Low$1.56
Low Change0.00 (0.00%)
High$1.59
High Change+0.03 (+1.87%)
Range$0.03
Volume1.001K
Dollar Volume$1.57K

Regular Trading Hours Yesterday

-0.04(-2.20%)
Open$1.59
Close$1.56
Low$1.55
Low Change-0.04 (-2.52%)
High$1.63
High Change+0.04 (+2.52%)
Range$0.08
Volume172.258K
Dollar Volume$267.86K

Premarket Yesterday

-0.02(-0.94%)
Open$1.60
Close$1.58
Low$1.58
Low Change-0.02 (-0.94%)
High$1.62
High Change+0.03 (+1.57%)
Range$0.04
Volume969
Dollar Volume$1.53K

BioXcel Therapeutics Statistics

Average Volume (30 Days)453.22K
P/E Ratio (Current)-.50
EPS (Current)-$3.12
Dividend Yield0.00%
Free Cash Flow
Cash Ratio0.96
Current Ratio1.14
Quick Ratio1.13
Debt to Equity-1.23
Enterprise Value$107.28M
EV to EBITDA-2.14
EV to Sales142.67
Price to Book-0.39
Price to Cash Flow
Price to Free Cash Flow
Price to Sales45.66
Return on Assets-1.52%
Return on Equity0.77%

BioXcel Therapeutics Stock Splits

There has been 1 stock split for BioXcel Therapeutics (BTAI). The reverse stock split occured on February 10, 2025 and reduced the outstanding shares at a ratio of 16:1.

DateTypeRatio
February 10, 2025Reverse16:1